Despite headlines suggesting a ban, the FDA has simply placed BPC-157 in a category requiring further investigation
Key Benefits: Comprehensive Anesthetic Coverage: Suitable for infiltration, nerve block, and epidural anesthesia, making it versatile for both minor and major procedures
Do not use in animals with known hypersensitivity to the active ingredient
Intramuscular Injection: Injecting directly into the muscle, sometimes near the site of an injury to potentially concentrate its healing effects locally
Acknowledgments This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract HHSN261201500003I
The LRI article cited above shares further key findings from other studies on epithalamin